CORCEPT THERAPEUTICS INC
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Corcept Therapeutics is a pharmaceutical company that develops and markets treatments based on the modulation of cortisol activity, including its approved drug for Cushing's syndrome, and is researching additional cortisol-related therapies for conditions such as certain cancers and psychiatric disorders.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Vieira Roberto WandenkolkPresident, Oncology | Sell | $109K | 974at $112.40 | Sep 2, 2026 |
| Vieira Roberto WandenkolkPresident, Oncology | Sell | $644K | 5,621at $114.58 | Sep 2, 2026 |
| Vieira Roberto WandenkolkPresident, Oncology | Sell | $183K | 1,606at $113.72 | Sep 2, 2026 |
| Vieira Roberto WandenkolkPresident, Oncology | Sell | $171K | 1,537at $111.37 | Sep 2, 2026 |
| Vieira Roberto WandenkolkPresident, Oncology | Sell | $141K | 1,225at $115.44 | Sep 2, 2026 |
| Maduck SeanSee Remarks | Sell | $1.34M | 11,730at $113.94 | Sep 1, 2026 |
| Maduck SeanSee Remarks | Sell | $1.26M | 10,989at $114.71 | Sep 1, 2026 |
| Maduck SeanSee Remarks | Sell | $264K | 2,281at $115.61 | Sep 1, 2026 |
| Vieira Roberto WandenkolkPresident, Oncology | Sell | $2.63M | 23,770at $110.70 | Sep 2, 2026 |
| Vieira Roberto WandenkolkPresident, Oncology | Sell | $2.58M | 23,600at $109.35 | Sep 2, 2026 |
| MAHONEY DAVID LInsider | Sell | $839K | 7,055at $118.88 | Aug 18, 2026 |
| MAHONEY DAVID LInsider | Sell | $585K | 4,984at $117.47 | Aug 18, 2026 |
| MAHONEY DAVID LInsider | Sell | $48K | 400at $119.64 | Aug 18, 2026 |
| MAHONEY DAVID LInsider | Sell | $10.78M | 91,167at $118.24 | Aug 18, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CORT activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.